A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
Condition(s):Severe Hemophilia A; Moderate Hemophilia ALast Updated:May 16, 2022Recruiting